METADATA last updated: 2026-03-17 RT file_name: _context-commentary_various-fl-presentations.md category: various subcategory: fl-presentations gfile_url: https://docs.google.com/document/d/19nNMVnaSUS_4hjWEnN_u7PRP-t3jdx_i1aump8AEvcw words: 1120 tokens: 1711 CONTENT ## Context The `various/fl-presentations` subcategory contains nine files: seven slide decks and two one-page summary documents (the quad charts and a COVID-19 tests summary sheet). Together they document how FloodLAMP presented itself and its technology to different external audiences between mid-2021 and mid-2022. The presentations were prepared for specific occasions and audiences: - `BARDA Market Research - FloodLAMP Presentation (2022-03-07)` was prepared for a formal market research call with BARDA and is the most comprehensive presentation in the subcategory. It covers the full FloodLAMP platform: assay technology (QuickColor LAMP and EasyPCR), real-world deployment data, the "point of need" operating model, digital tools, clinical evaluation results from Stanford, the open EUA regulatory strategy, and the case for variant resilience through multi-gene molecular testing. - `New England Biolabs (NEB) Presentation - FloodLAMP (3-3-2022)` (March 3, 2022) was prepared for an invited talk at NEB's facilities in Massachusetts. It shares substantial content with the BARDA deck but includes additional operational detail on specific pilot sites, a detailed preschool family screening case report, a New Year's Eve case report demonstrating early detection versus antigen and other rapid molecular tests, and more technical content on LAMP assay components, training workflows, and quality systems. - `FDA Reagan Udall Foundation - FloodLAMP Presentation (4-21-2022)` (April 21, 2022) was given during their monthly call, and presents a condensed version of FloodLAMP's vision and platform, emphasizing regulatory framing: the "open protocol" EUA concept, real-world surveillance data through the Omicron surge, and clinical evaluation results. - `FTFC EMS Conference - FloodLAMP Talk Slides (6-14-2021)` (June 14, 2021) is the earliest presentation in the set, prepared for an invited talk at a FTFC/Eagles EMS leadership conference in Ft. Lauderdale, FL. It covers the core assay technology, clinical evaluation data, the school screening model, regulatory pathways and challenges, the open EUA comparison table, and the competitive landscape for K-12 screening providers. - `Florida EMS Departments - FloodLAMP Slides (Aug 2022)` (August 2022) targets EMS organizations and focuses on practical "point of need" deployment: FloodLAMP's advantages over CLIA-dependent and antigen-based alternatives, the turnkey solution including pooled collection, mobile app, training and quality system, and operational mechanics for an EMS employer screening program. - `Quad Chart v1 - FloodLAMP (Dec 2021)` (December 2021) and `Quad Chart v2 - FloodLAMP (Jan 2022)` (January 2022) are structured one-page briefs summarizing objectives, deployments, performance metrics, milestones, risks, and funding structure for potential government or institutional funders. - `Bend Pilot Program Bring-up (12-01-2021)` (December 1, 2021) is a site bring-up training deck prepared for the remote onboarding of Bend Fire and Rescue in Bend, OR. It combines an abbreviated FloodLAMP overview and case studies with hands-on training sections covering safety highlights, contamination procedures (RNAse, positive control, sample cross-contamination, and amplicon contamination), a test system overview of the QuickColor LAMP workflow, and a validation run protocol with training kit inventory. - `FloodLAMP - COVID-19 Tests Summary` (May 2021) is a single-page overview of the two FloodLAMP tests, digital tools, clinical evaluation status, and regulatory posture. There is considerable content overlap across the presentations, particularly between the BARDA and NEB decks. Collectively, the presentations show FloodLAMP's evolution. Recurring themes include the "sweet spot" positioning of LAMP between antigen tests and centralized PCR, the open EUA strategy, real-world pilot data, and the vision for decentralized "point of need" molecular testing. Related materials include the proposals in `various/fl-proposals`, pilot program documentation in `pilots/pilot-data` and `pilots/pilot-sites`, the regulatory submissions in `regulatory/fl-fda-submissions`, the preschool whitepaper in `various/fl-whitepapers`, the open EUA concept explored in `regulatory/open-euas`, and the gLAMP consortium review paper in `various/glamp`. ### Archive Files Not Converted to Markdown `Conference Talk by FloodLAMP - Back To School COVID Testing Conference (Las Vegas 4-13-2021).pdf` `Conference Talk by FloodLAMP - Back To School COVID Testing Conference (Las Vegas 4-13-2021).pptx` `FloodLAMP Early Deck - Focus on Foundations Nonprofit (6-25-2020).pdf` `gLAMP Presentation - FloodLAMP (12-10-2020).pdf` `gLAMP Presentation - FloodLAMP (12-10-2020).pptx` `Pilot Site Bend Oregon Bringup - FloodLAMP (12-01-2021).pdf` `Pilot Site Bend Oregon Bringup - FloodLAMP (12-01-2021).pptx` ## Commentary Communicating FloodLAMP's full picture, from the science to the operational model to the regulatory vision, was a persistent challenge. The company was attempting something unusual: not just a new test, but a complete decentralized screening platform with an open-source regulatory strategy, and that combination was difficult to convey in a slide deck. Moreover, FloodLAMP was a mission-driven Public Benefit Corporation, so from a legal organization perspective, FloodLAMP fit between an open-source/nonprofit and a for-profit C-corp startup. The presentations in this subcategory reflect these challenges, as well as the shifting strategic priorities as the company moved from pursuing FDA EUA authorization to building surveillance programs to seeking government funding and partnerships. The overlap between presentations illustrates both the core consistency of what FloodLAMP was building and the incremental adaptations made for each audience. The BARDA deck and NEB seminar, prepared days apart in early March 2022, represent the most mature articulation of the platform. By that point FloodLAMP had accumulated meaningful real-world data from multiple pilot sites and could present concrete screening statistics, nearly 30,000 people screened and hundreds of positives detected, alongside the clinical evaluation results from Stanford. The audience for these presentations ranged widely: BARDA officials evaluating market readiness, NEB scientists interested in LAMP assay protocols, EMS leaders wanting practical deployment details, and FDA-adjacent stakeholders focused on regulatory issues. Both the open EUA concept and surveillance operations, which were central to FloodLAMP's strategy, required particularly careful framing because they challenged fundamental regulatory policy. The earlier FTFC EMS conference deck (June 2021) is notable for carrying a more overtly commercial tone, reflecting a period when FloodLAMP was still positioning for growth. By the time of the BARDA and NEB presentations in early 2022, the framing had changed. The later Florida EMS deck (August 2022) returned to a more practical, deployment-focused pitch. The Bend bring-up deck stands apart from the other presentations as the only training-oriented slide deck in the subcategory. Its contamination procedures section is notable for the effort to communicate the dual nature of contamination vigilance to a non-scientist EMS audience: on one hand, keeping RNAse and environmental contaminants out of the labware and reagents to protect the integrity of the test; on the other hand, treating positive controls and amplified products as if radioactive, with rigorous protocols (glove changes, dedicated zones, never opening amplified tubes) to prevent those high-concentration targets from spreading through the lab. The framing of the amplification area as a "black hole" where nothing comes out, and the emphasis on the CDC's own contamination incident as a cautionary example, reflect the mental models FloodLAMP developed to make contamination management intuitive for non-laboratory personnel. See `pilots/pilot-data` for additional context on the Bend pilot program and `guides/test-site` for the collection of practical how-to and related archive files.